Nuheara (ASX:NUH) -
Source: Nuheara
Market Herald logo


Be the first with the news that moves the market
  • Hearing aid developer Nuheara (NUH), has launched the next generation of hearable technology, IQbuds MAX
  • The IQbuds MAX feature hybrid Active Noise Cancellation, sonic accuracy and unique features giving the wearer complete control over sounds
  • CEO Justin Miller claims due to several hardware and software breakthroughs in the past year, Nuheara was able to bring out the IQbuds MAX sooner than anticipated
  • The company will showcase the device’s features at the CES Unveiled event today in Las Vegas
  • Nuheara shares remain flat and are trading for 3.6 cents each

Hearing technology developer Nuheara (NUH), has launched its next generation of hearable technology, IQbuds MAX.

Nuheara develops smart personal hearing devices which enhances the lives of people who have hearing impairments.

Built on Nuheara’s innovative new smart-hearing platform, the IQbuds2 MAX feature hybrid Active Noise Cancellation as well as unique features for personalising and enhancing the wearer’s soundscape.

Key developments include sonic accuracy, advanced digital signal processing, situational sound, true personalisation and hybrid active noise cancellation.

The company redesigned the device using its latest acoustic technology, EarID. The EarID technology and Speech in Noise Control (SINC) enhances normal hearing and allows users to “fine-tune” their hearing experience.

“We’ve incorporated major engineering enhancements, such as better drivers for improved sonic accuracy and design features that fit more processing power into a comfortable earbud,” CEO Justin Miller said.

The CEO claims due to several hardware and software achievements in the past year, the company was able to bring out the IQbuds2 MAX sooner than anticipated.

The IQbuds2 MAX replace the previously announced IQbuds MAX.

The company will showcase its superiority for the first time in Las Vegas at CES Unveiled today.

Nuheara shares remain flat and are trading for 3.6 cents each at 11:33 am AEDT.

NUH by the numbers
More From The Market Herald
The Market Herald Video

" Emyria (ASX:EMD) launches phase 3 EMD-RX5 trial

Emyria (ASX:EMD) has launched its phase three clinical trial of its ultra-pure CBD candidate.
The Market Herald Video

" Prescient Therapeutics (ASX:PTX) locks in OmniCAR cell manufacturing contract for clinical trials

Prescient Therapeutics (ASX:PTX) has signed a manufacturing services agreement with Q-Gen Cell Therapeutics to produce its…
The Market Herald Video

" Opthea (ASX:OPT) secures up to US$260m in funding for OPT-302 trials

Opthea (ASX:OPT) secures up to US$170 million in financing and a US$90 million placement to advance…
Creso Pharma (ASX:CPH) -

" Creso Pharma’s (ASX:CPH) ImpACTIVE appoints new brand ambassador

Creso Pharma's (ASX:CPH) subsidiary, ImpACTIVE has appointed multi-sport performance coach Kolby Tullier as brand ambassador.